Pancreatic endocrine carcinoma
MONDO:0005893An aggressive, high-grade and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the pancreas. The mitotic count is more than 20 per 10 HPF. According to the size of the malignant cells, the prominence of the nucleoli, and the amount of cytoplasm, it is classified either as small or large cell neuroendocrine carcinoma.
Also known as: Pancreatic Neuroendocrine cancer, carcinoma of endocrine pancreas, carcinoma, islet cell, malignant, endocrine pancreas carcinoma, high grade pancreatic neuroendocrine carcinoma, high-grade pancreatic neuroendocrine carcinoma, islet cell cancer, islet cell carcinoma
2919 clinical trials for this condition and its sub-types, 12 tagged with Pancreatic endocrine carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Pancreatic endocrine carcinoma
-
New drug BL-M14D1 targets tough cancers in early human trial
Disease control Recruiting nowThis early-stage trial is testing a new drug called BL-M14D1 in about 120 people with advanced small cell lung cancer or other neuroendocrine cancers that have spread or cannot be removed. The drug works by homing in on a protein called DLL3 found on these cancer cells and delive…
Phase 1 • Sponsor: SystImmune Inc. • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Experimental drug tarlatamab takes on rare, Tough-to-Treat cancer
Disease control Recruiting nowThis phase 2 trial is testing a drug called tarlatamab in 60 adults with advanced extrapulmonary neuroendocrine carcinoma, a rare cancer that has come back after standard chemotherapy. Tarlatamab works by helping the body's immune cells find and attack cancer cells. The main goal…
Phase 2 • Sponsor: Inkeun Park • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
FITBIT FOR CANCER: STUDY TESTS IF STEP COUNTS PREDICT SURVIVAL
Knowledge-focused Recruiting nowThis study is testing whether wearing a fitness tracker (like a Fitbit) can give doctors a better picture of how active cancer patients are, and whether that activity level relates to how well they are doing overall. About 590 people with various cancers will wear activity monito…
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jul 17, 2026 00:00 UTC
-
Massive pancreas tissue bank launches to unlock disease secrets
Knowledge-focused Recruiting nowThis study collects blood, tissue, and health information from 20,000 people with pancreas diseases like pancreatic cancer, pancreatitis, or cysts. The goal is to create a large database and sample bank that researchers can use to better understand these conditions and develop be…
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC